Aileron Stock Future Price Prediction

ALRN
 Stock
  

USD 2.81  0.06  2.18%   

Aileron Therapeutics stock price prediction is an act of determining the future value of Aileron Therapeutics shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Aileron Therapeutics' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Aileron Therapeutics and does not consider all of the tangible or intangible factors available from Aileron Therapeutics' fundamental data. We analyze noise-free headlines and recent hype associated with Aileron Therapeutics, which may create opportunities for some arbitrage if properly timed.
Please continue to Aileron Therapeutics Basic Forecasting Models to cross-verify your projections.
  
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Aileron Therapeutics based on different types of headlines from major news networks to social media. The Aileron stock price prediction module provides an analysis of price elasticity to changes in media outlook on Aileron Therapeutics over a specific investment horizon.
EPS Estimate Next Quarter
(0.08) 
EPS Estimate Current Year
(6.37) 
EPS Estimate Next Year
(4.60) 
Wall Street Target Price
40.0
EPS Estimate Current Quarter
(0.08) 
Using Aileron Therapeutics hype-based prediction, you can estimate the value of Aileron Therapeutics from the perspective of Aileron Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
Aileron Therapeutics Price to Book Value is quite stable at the moment as compared to the past year. The company's current Price to Book Value is estimated at 1.41. Tangible Assets Book Value per Share is expected to rise to 0.56 this year, although the value of Cash Flow Per Share will most likely fall to (1.84) .

Aileron Therapeutics Hype to Price Pattern

Investor biases related to Aileron Therapeutics' public news can be used to forecast risks associated with investment in Aileron. The trend in average sentiment can be used to explain how an investor holding Aileron can time the market purely based on public headlines and social activities around Aileron Therapeutics. Please note that most equiteis that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Aileron Therapeutics' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Aileron Therapeutics.
This module is based on analyzing investor sentiment around taking a position in Aileron Therapeutics. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Aileron Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Aileron because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Aileron Therapeutics after-hype prediction price

    
  USD 3.5  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Aileron Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Aileron Therapeutics in the context of predictive analytics.
Intrinsic
Valuation
LowReal ValueHigh
0.122.359.56
Details
2 Analysts
Consensus
LowTarget PriceHigh
2.002.002.00
Details
Earnings
Estimates (2)
LowProjected EPSHigh
-0.3-0.3-0.3
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Aileron Therapeutics. Your research has to be compared to or analyzed against Aileron Therapeutics' peers to derive any actionable benefits. When done correctly, Aileron Therapeutics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Aileron Therapeutics.

Aileron Therapeutics After-Hype Price Prediction Density Analysis

As far as predicting the price of Aileron Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Aileron Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Aileron Therapeutics, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Aileron Therapeutics Estimiated After-Hype Price Volatility

In the context of predicting Aileron Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Aileron Therapeutics' historical news coverage. Aileron Therapeutics' after-hype downside and upside margins for the prediction period are 0.18 and 10.71, respectively. We have considered Aileron Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value 2.81
3.50
After-hype Price
10.71
Upside
Aileron Therapeutics is dangerous asset. Analysis and calculation of next after-hype price of Aileron Therapeutics is based on 3 months time horizon.

Aileron Therapeutics Stock Price Prediction Analysis

Have you ever been surprised when a price of a company such as Aileron Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Aileron Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Aileron Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.16  7.21  0.69   0.04  2 Events / Month0 Events / MonthIn a few days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
2.813.5024.56 
168.07  

Aileron Therapeutics Hype Timeline

Aileron Therapeutics is presently traded for 2.81. The entity has historical hype elasticity of 0.69 and average elasticity to hype of competition of 0.04. Aileron is projected to increase in value after the next headline with the price projected to jump to 3.5 or above. The average volatility of media hype impact on the company stock price is about 168.07%. The price upswing on the next news is forecasted to be 24.56% whereas the daily expected return is presently at -0.16%. The volatility of related hype on Aileron Therapeutics is about 3277.27% with expected price after next announcement by competition of 2.85. The company currently holds 100 K in liabilities with Debt to Equity (D/E) ratio of 0.0, which may suggest the company is not taking enough advantage from borrowing. Aileron Therapeutics has a current ratio of 6.38, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Aileron Therapeutics until it has trouble settling it off, either with new capital or with free cash flow. So, Aileron Therapeutics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Aileron Therapeutics sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Aileron to invest in growth at high rates of return. When we think about Aileron Therapeutics' use of debt, we should always consider it together with cash and equity.Given the investment horizon of 90 days the next projected press release will be in a few days.
Please continue to Aileron Therapeutics Basic Forecasting Models to cross-verify your projections.

Aileron Therapeutics Related Hype Analysis

Having access to credible news sources related to Aileron Therapeutics' direct competition is more important than ever and may enhance your ability to predict Aileron Therapeutics' future price movements. Getting to know how Aileron Therapeutics rivals react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Aileron Therapeutics may potentially react to the hype associated with one of its peers.

Aileron Therapeutics Additional Predictive Modules

Most predictive techniques to examine Aileron price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Aileron using various technical indicators. When you analyze Aileron charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Aileron Therapeutics Predictive Indicators

The successful prediction of Aileron Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Aileron Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Aileron Therapeutics based on analysis of Aileron Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Aileron Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Aileron Therapeutics's related companies.

Story Coverage note for Aileron Therapeutics

The number of cover stories for Aileron Therapeutics depends on current market conditions and Aileron Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Aileron Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Aileron Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Aileron Therapeutics Short Properties

Aileron Therapeutics' future price predictability will typically decrease when Aileron Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Aileron Therapeutics often depends not only on the future outlook of the potential Aileron Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Aileron Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding1966058.85
Cash And Short Term Investments45933000.00
Please continue to Aileron Therapeutics Basic Forecasting Models to cross-verify your projections. You can also try Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Complementary Tools for analysis

When running Aileron Therapeutics price analysis, check to measure Aileron Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aileron Therapeutics is operating at the current time. Most of Aileron Therapeutics' value examination focuses on studying past and present price action to predict the probability of Aileron Therapeutics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Aileron Therapeutics' price. Additionally, you may evaluate how the addition of Aileron Therapeutics to your portfolios can decrease your overall portfolio volatility.
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Is Aileron Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aileron Therapeutics. If investors know Aileron will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aileron Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
12.5 M
Return On Assets
(0.45) 
Return On Equity
(0.81) 
The market value of Aileron Therapeutics is measured differently than its book value, which is the value of Aileron that is recorded on the company's balance sheet. Investors also form their own opinion of Aileron Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Aileron Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aileron Therapeutics' market value can be influenced by many factors that don't directly affect Aileron Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aileron Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine Aileron Therapeutics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aileron Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.